Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 11 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

11 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Aug. 8, 2014 IART S 1,947 $48.28 $94,001 7,069 Direct -21.59% Disposed -47.5% (price as of 2026-10-02)
Feb. 27, 2014 IART S 3,265 $46.15 $150,680 10,256 Direct -24.15% Disposed -45.0% (price as of 2026-10-02)
Aug. 19, 2013 IART S 7,490 $41.90 $313,831 13,521 Direct -35.65% Disposed -39.5% (price as of 2026-10-02)
May 21, 2013 IART S 200 $36.86 $7,372 21,498 Direct -0.92% Disposed -31.2% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Dec. 10, 2012 IART Common Stock 20,978 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

IART

President — Global Spine & Orthobiologics & Head of Strategic Development (20)
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2013 $336,615 · · · · · $4,125 $470,815

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.